News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML
Talha Badar/X
Mar 4, 2025, 10:55

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Jing Lu, et al. on X:

“Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Venetoclax plus decitabine NOT INFERIOR to intensive chemo in young fit AML.

VEN+DEC was well tolerated.”

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Authors: Jing Lu, et al.

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

 

AML cancer chemotherapy decitabine fight against cancer Global fight against cancer Jing Lu Mayo Clinic OncoDaily Oncology Talha Badar venetoclax
Special Coverage
Blog
Jun 12, 2025, 12:02
"Lung Cancer Is Treatable, and Patients Deserve to Know That" – ACS NLCRT on Shifting the Narrative in Cancer Care
Blog
Jun 12, 2025, 11:43
Rebecca Williams-Barbieri Marks 20 Years at Memorial Sloan Kettering Cancer Center
Blog
Jun 12, 2025, 11:40
Luca Arecco: Beautiful Return to Porto Antico Genova of the Amerigo Vespucci After 2 Years
Blog
Jun 12, 2025, 11:29
Roman Kizyma Shares Update on New St. Jude Grants for Pediatric Hematology-Oncology in Ukraine
Blog
Jun 12, 2025, 11:21
Applications are Open for the ESO's Certificate of Competence in Breast Cancer - Sixth Cohort
Blog
Jun 12, 2025, 11:19
Bob Li Visited Jules Bordet Institute and Discussed Clinical Trial Access with Oncology Leaders
Blog
Jun 12, 2025, 10:54
Raffaele Colombo: Sacituzumab Tirumotecan Versus Docetaxel in EGFR-Mutated Advanced NSCLC
Blog
Jun 12, 2025, 10:49
Talha Badar: AML-BFM Study Group Recommendations on Pediatric Therapy-Related AML
Blog
Jun 12, 2025, 10:49
The world's top myeloma experts are going to share updates on groundbreaking research at the IMWG Summit
Blog
Jun 12, 2025, 10:47
Nicole Grogan Fleege Shares Reflections on Mentoring Her First Full Fellowship Class
Career
Jun 12, 2025, 10:43
Congrats to Maria Farooq and Chirayu Mohindroo for Receiving 2025 Young Investigator Awards - NCI Center for Cancer Research
Blog
Jun 12, 2025, 10:39
Kai-Keen Shiu Shares Post-ASCO Reflections on GI Cancer Advances